THE NEW YORK TIMES
May 5, 2017
By Denise Grady
"A new drug for amyotrophic lateral sclerosis, or Lou Gehrig’s disease, was approved on Friday by the Food and Drug Administration...
Dr. Neil A. Shneider, director of the Eleanor and Lou Gehrig ALS Center at Columbia University Medical Center, said, 'The effect is modest but significant.'